The Pluta Cancer Foundation has committed $4 million to UR Medicine’s Wilmot Cancer Institute.

“We are incredibly grateful to the Pluta Cancer Foundation for these investments and for its longtime commitment to cancer patients, survivors, and the community,” said David Linehan MD, CEO of the University of Rochester Medical Center, dean of the School of Medicine and Dentistry and senior vice president for health sciences. “The foundation’s generosity will enhance research opportunities, support innovative teaching initiatives and attract leading experts in cancer care.”
Ron Pluta, chair of the Pluta Cancer Foundation board, said the foundation and Wilmot are singularly focused on helping those with a cancer diagnosis at all stages of their treatment, care and recovery.
“We’re proud to make this commitment, which is possible through the generosity of all our donors over the years,” Pluta said. “This truly aligns with our mission to support cancer patients and invest in the professional development of those on the frontlines of patient care.”
[email protected] / (585) 653-4021
d